These authors contributed equally.
Phosphatidylserine exposure and procoagulant activity in acute promyelocytic leukemia
Article first published online: 21 JAN 2010
© 2010 International Society on Thrombosis and Haemostasis
Journal of Thrombosis and Haemostasis
Volume 8, Issue 4, pages 773–782, April 2010
How to Cite
ZHOU, J., SHI, J., HOU, J., CAO, F., ZHANG, Y., RASMUSSEN, J. T., HEEGAARD, C. W. and GILBERT, G. E. (2010), Phosphatidylserine exposure and procoagulant activity in acute promyelocytic leukemia. Journal of Thrombosis and Haemostasis, 8: 773–782. doi: 10.1111/j.1538-7836.2010.03763.x
- Issue published online: 23 MAR 2010
- Article first published online: 21 JAN 2010
- Received 30 November 2009, accepted 11 January 2010
- 115/17 translocation, a consistent chromosomal change in acute promyelocytic leukaemia. Lancet 1977; 1: 549–50., , .
- 2The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus. Nature 1990; 347: 558–61., , , , .
- 3Abnormalities in hemostasis in acute promyelocytic leukemia. Hematol Oncol 2002; 20: 33–41., , .
- 4Annexin II and bleeding in acute promyelocytic leukemia. N Engl J Med 1999; 340: 994–1004., , , , , .
- 5Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group. Blood 1993; 82: 3241–9., , , , , , , , , , , , , , , , , , , , et al.
- 6Acute promyelocytic leukemia: from highly fatal to highly curable. Blood 2008; 111: 2505–15., .
- 7How acute promyelocytic leukaemia revived arsenic. Nat Rev Cancer 2002; 2: 705–13., , , .
- 8Tissue factors on acute promyelocytic leukemia and endothelial cells are differently regulated by retinoic acid, arsenic trioxide and chemotherapeutic agents. Leukemia 1999; 13: 1062–70., , , , , , , , , , , , , .
- 9Studies of the procoagulant and fibrinolytic activity of promyelocytes in acute promyelocytic leukaemia. Br J Haematol 1973; 24: 89–99., .
- 10The procoagulant factor of leukaemic promyelocytes: demonstration of immunologic cross reactivity with human brain tissue factor. Br J Haematol 1975; 30: 151–8., , , .
- 11Cancer procoagulant in the human promyelocytic cell line NB4 and its modulation by all-trans-retinoic acid. Leukemia 1994; 8: 156–9., , , , , , , .
- 12Tissue factor encryption. Arterioscler Thromb Vasc Biol 2006; 26: 456–61..
- 13Surface-dependent reactions of the vitamin K-dependent enzyme complexes. Blood 1990; 76: 1–16., , , , .
- 14Thrombogenic role of cells undergoing apoptosis. Br J Haematol 2001; 115: 382–91., , , .
- 15Functional analyses of two cellular binding domains of bovine lactadherin. Biochemistry 2000; 39: 6200–6., , , , .
- 16Lactadherin binds selectively to membranes containing phosphatidyl-L-serine and increased curvature. Biochim Biophys Acta 2004; 1667: 82–90., , , .
- 17Lactadherin inhibits enzyme complexes of blood coagulation by competing for phospholipid binding sites. Blood 2003; 101: 2628–36., .
- 18Lactadherin detects early phosphatidylserine exposure on immortalized leukemia cells undergoing programmed cell death. Cytometry A 2006; 69: 1193–201., , , , , .
- 19Lactadherin blocks thrombosis and hemostasis in vivo: correlation with platelet phosphatidylserine exposure. J Thromb Haemost 2008; 6: 1167–74., , , , .
- 20Membrane phosphatidylserine regulates surface charge and protein localization. Science 2008; 319: 210–3., , , , , .
- 21NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood 1991; 77: 1080–6., , , , , .
- 22Crystal structure of lactadherin C2 domain at 1.7A resolution with mutational and computational analyses of its membrane-binding motif. J Biol Chem 2008; 283: 7230–41., , , , .
- 23Cell surface-expressed phosphatidylserine and annexin A5 open a novel portal of cell entry. J Biol Chem 2004; 279: 52623–9., , , , , , , .
- 24Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 1994; 84: 1415–20., , , , , .
- 25Factor VII binding to tissue factor in reconstituted phospholipid vesicles: induction of cooperativity by phosphatidylserine. Biochemistry 1986; 25: 4007–20., , .
- 26Effect of P-selectin on phosphatidylserine exposure and surface-dependent thrombin generation on monocytes. Arterioscler Thromb Vasc Biol 2005; 25: 1065–70., , , , , .
- 27Tissue factor de-encryption: ionophore treatment induces changes in tissue factor activity by phosphatidylserine-dependent and -independent mechanisms. Blood Coagul Fibrinolysis 1999; 10: 201–10., , , .
- 28An in vitro study on the mechanisms of coagulation activation in acute myelogenous leukemia (AML): role of tissue factor regulation by cytotoxic drugs and GM-CSF. Thromb Haemost 2004; 92: 1136–46., , , , , , , .
- 29Ligand-induced protease receptor translocation into caveolae: a mechanism for regulating cell surface proteolysis of the tissue factor-dependent coagulation pathway. J Cell Biol 1996; 133: 293–304., , .
- 30Lipid rafts are necessary for tonic inhibition of cellular tissue factor procoagulant activity. Blood 2004; 103: 3038–44., , .
- 31Domain formation in a fluid mixed lipid bilayer modulated through binding of the C2 protein motif. Biochemistry 2001; 40: 4181–91., , , .
- 32Characterization of cholesterol-sphingomyelin domains and their dynamics in bilayer membranes. Biophys J 2001; 81: 1486–500., , .
- 33Isolation and characterization of cancer procoagulant: a cysteine proteinase from malignant tissue. Biochemistry 1985; 24: 5558–67., .